Pixeom Raises Seed Round

Pixeom, an Oita City-based software company specializing in chemical vision AI, has successfully raised seed funding. The company, which originated from Oita University, focuses on proprietary AI technology that converts three-dimensional molecular structures into learnable data representations to improve drug discovery processes.

Investors

The funding round was led by Lifetime Ventures, which provided both capital and strategic business guidance to support the company's growth in the pharmaceutical and life sciences sectors.

Pixeom Use of Funds

Pixeom plans to utilize the capital to accelerate the research, development, and commercialization of its chemical visual AI platform. Specifically, funds will be directed toward upgrading its AI computing environment, enhancing research and development facilities, and expanding collaborative proof-of-concept projects with partners in the pharmaceutical and drug discovery industries.

About Pixeom

Founded as a university-originated startup, Pixeom develops AI-driven platforms for drug discovery and chemical research. Their core technology, the Proximity Score Matrix, enables AI to analyze molecular structure data more effectively, aiming to transform academic and institutional research data into actionable drug discovery tools.

Funding Details

Company Website: https://pixeom.jp

Company: Pixeom Co., Ltd.
Round: Seed
Funding Date: September 9, 2026
Lead Investor: Lifetime Ventures
Company Website: https://pixeom.jp/
Software Category: AI-driven drug discovery
Source: https://prtimes.jp/main/html/rd/p/000000003.000190076.html